Clinical Trials
Sinapis Pharma concludes Phase I stroke drug trial
Sinapis Pharma has concluded first Phase I clinical trial of oral and IV administration of methamphetamine HCl for the treatment of stroke and traumatic brain...
Clinical Trials
Phase 3 Study of YERVOY Metastatic Melanoma Meets Primary...
Bristol-Myers Squibb Company announced results from a second Phase 3 randomized, double blind study demonstrating that YERVOYâ„¢ (ipilimumab) prolonged the lives of patients with metastatic...
Clinical Trials
Roche announces data to show Avastin based regimen halved...
Roche announced results from OCEANS, a phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of...
Clinical Trials
Adaptimmune announces Opening of Phase I/II Clinical Trial in...
Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the...
Clinical Trials
First ever study to apply therapeutic approach of global...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard (Lyon), the major...
Clinical Trials
FDA approves linagliptin tablets for the treatment of type...
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used along...
Clinical Trials
Gilead and MicroDose Therapeutx Announce License and Collaboration Agreement...
Gilead Sciences, Inc. and MicroDose Therapeutx, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.